RNA Therapeutics, 16th & 17th February 2015, Marriott Regents Park Hotel, London UK

LONDON, LONDON, UNITED KINGDOM, November 6, 2014 /EINPresswire.com/ -- In recent days, Roche announced the launch of the SeqCap RNA Target Enrichment System for RNA-Seq applications. The system was designed to enable researchers to achieve significantly enhanced discovery power and targeting efficiency of RNA-Seq. Researchers in next-generation sequencing are increasingly studying RNA to more deeply understand transcript changes in order to identify potential genetic drivers for diseases.*

Hear more from Roche at SMi’s 6th annual conference next February on RNA Therapeutics in a presentation entitled RNA Therapeutics – Unlocking the potential with locked nucleic acids. Bo Rode Hansen, Vice President of Drug Discovery & Alliance from Roche, will discuss:

• Lessons learnt and new developments following several decades of RNA Therapeutics
• Reasons as to why the success rate of RNA therapeutics drug development have been low with very few marketed drugs as a result
• The most recent thinking on how to increase productivity of RNA therapeutics development
• Nucleic acids and the reasons as to why Roche has chosen this as a preferred chemistry and modality for RNA therapeutics development

Other key speakers include: Silence Therapeutics, CRISPR Therapeutics, Leiden University Medical Centre, MiNa Therapeutics, AstraZeneca and GSK.

For those who are interested in attending, there is currently a £100 discount available online for bookings made this month. For further details or to download a brochure, visit www.therapeutics-rna.com

RNA Therapeutics: From Cell to Sales – Clearing the Path to Market
16-17 February 2015
Marriott Regents Park Hotel, London UK
www.therapeutics-rna.com

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

* Source: http://www.pharmabiz.com/NewsDetails.aspx?aid=84864&sid=2

Teri Arri
SMi Group Ltd
+44 (0)20 7827 6162
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.